Literature DB >> 3951995

Synthesis of 5-chloroformycin A, 5-chloro-2'-deoxyformycin A and certain related 5,7-disubstituted 3-beta-D-ribofuranosylpyrazolo[4,3-d] pyrimidines from formycin A.

K G Upadhya, Y S Sanghvi, R K Robins, G R Revankar, B G Ugarkar.   

Abstract

A facile synthesis of 7-amino-5-chloro-3-beta-D-ribofuranosylpyrazolo [4,3-d]pyrimidine (5-chloroformycin A, 6), 7-amino-5-chloro-3-(2-deoxy-beta-D-erythro-pentofuranosyl) pyrazolo [4,3-d]-pyrimidine (5-chloro-2'-deoxyformycin A, 13) and certain related 5,7-disubstituted pyrazolo[4,3-d]pyrimidine ribonucleosides is described starting with formycin A. Thiation of tri-O-acetyloxoformycin B (4b) with phosphorus pentasulfide, followed 3-beta-D-ribofuranosyl-7-thioxopyrazolo[4,3-d] pyrimidin-5(1H,4H,6H)-one (3b) in excellent yield. Chlorination of 4b with either phosphorus oxychloride or phenyl phosphonicdichloride furnished the key intermediate 5,7-dichloro-3-(2,3, 5-tri-O-acetyl-beta-D-ribofuranosyl)pyrazolo[4,3-d]pyrimidine (5a), which on deacetylation afforded 5,7-dichloro-3-beta-D-ribofuranosylpyrazolo [4,3-d]pyrimidine (5b). Ammonolysis of 5a with liquid ammonia gave 6, whereas with MeOH/NH3, a mixture of 6 and 7-methoxy-5-chloro-3-beta-D-ribofuranosylpyrazolo[4,3-d]pyrimidine (7) was obtained. Reaction of 6 with lithium azide and subsequent hydrogenation afforded 5-aminoformycin A (10). Treatment of 5a with thiourea gave 5-chloro-3-(2,3,5-tri-O-acetyl-beta-D-ribofuranosyl) pyrazolo[4,3-d]pyrimidine-7(1H,6H)-thione (8a), which on further reaction with sodium hydrosulfide furnished 3-beta-D-ribofuranosylpyrazolo [4,3-d]pyrimidine-5,7(1H,4H,6H)-dithione (11). The four-step deoxygenation procedure using phenoxythiocarbonylation of the 2'-hydroxy group of the 3', 5'-protected 6 gave 5-chloro-2'-deoxyformycin A (13).

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3951995      PMCID: PMC339570          DOI: 10.1093/nar/14.4.1747

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  30 in total

1.  Formycin anhydronucleosides. Conformation of formycin and conformational specificity of adenosine deaminase.

Authors:  J Zemlicks
Journal:  J Am Chem Soc       Date:  1975-10-01       Impact factor: 15.419

2.  Synthesis of C nucleosides X. Structural analogs of formycin B.

Authors:  T Huynh-Dinh; A Kolb; C Gouyette; J Igolen
Journal:  J Org Chem       Date:  1975-09-19       Impact factor: 4.354

3.  Cyclic phosphates of formycin.

Authors:  O Makabe; A Miyadera; M Kinoshita; S Umezawa
Journal:  J Antibiot (Tokyo)       Date:  1978-05       Impact factor: 2.649

4.  Antiviral and antimetabolic activities of formycin and its N1-, N2-, 2'-O- and 3'-O-methylated derivatives.

Authors:  J Giziewicz; E De Clercq; M Luczak; D Shugar
Journal:  Biochem Pharmacol       Date:  1975-10-01       Impact factor: 5.858

5.  The metabolism of formycin B in Leishmania donovani.

Authors:  D J Nelson; S W Lafon; T E Jones; T Spector; R L Berens; J J Marr
Journal:  Biochem Biophys Res Commun       Date:  1982-09-16       Impact factor: 3.575

6.  Metabolism and mechanism of action of formycin B in Leishmania.

Authors:  P Rainey; D V Santi
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

7.  Deoxycytidine kinase-mediated toxicity of deoxyadenosine analogs toward malignant human lymphoblasts in vitro and toward murine L1210 leukemia in vivo.

Authors:  D A Carson; D B Wasson; J Kaye; B Ullman; D W Martin; R K Robins; J A Montgomery
Journal:  Proc Natl Acad Sci U S A       Date:  1980-11       Impact factor: 11.205

8.  Synthesis and antiviral activity of certain carbamoylpyrrolopyrimidine and pyrazolopyrimidine nucleosides.

Authors:  R J Goebel; A D Adams; P A McKernan; B K Murray; R K Robins; G R Revankar; P G Canonico
Journal:  J Med Chem       Date:  1982-11       Impact factor: 7.446

9.  Has the well gone dry? The First Cain Memorial Award Lecture.

Authors:  J A Montgomery
Journal:  Cancer Res       Date:  1982-10       Impact factor: 12.701

10.  Effects of a new adenosine deaminase inhibitor, isocoformycin, on toxicity, antitumor activity and tissue distribution of formycin A and 9-beta-D-arabinofuranosyladenine.

Authors:  T Hidaka; K Katayama; K Yamashita; T Yamashita; K Watanabe; M Shimazaki; M Ohno; T Takeuchi; H Umezawa
Journal:  J Antibiot (Tokyo)       Date:  1980-03       Impact factor: 2.649

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.